Official Title: PROSPECTIVE STUDY OF HPV SPECIFIC IMMUNOTHERAPY IN SUBJECTS WITH HPV ASSOCIATED HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC a) NCT Number: NCT02 163057 Document Date : Protocol Version 2.1: 08 April 2016 CLINICAL RESEARCH PROTOCOL Prospective Study of HPV Specific Immunotherapy in Subjects with HPV Associated Head and Neck Squamous Cell Carcinoma (HNSCCa) Principal Investigator: , MD, MPH Protocol Version 2.1 Medical Oncology , MD , MD , MD Head and Neck Surgery Jr, MD , MD , MD , MD , MD Radiation Oncology , MD , MD , MD Basic Science Expert , PhD Drug Manufacturer/Sponsor Inovio Pharmaceuticals , Inc. 660 W Germantown Pike, Suit e 110 Plymouth Meeting, P A 19462 Research Correlative S tudies , PhD B iostatistics , PhD Medical M onitor , MD IND # 15946, under Inovio, Inc.